Roche's third quarter sales beat market expectations
Drugs and diagnostic company Roche said its third-quarter sales gained a currency-adjusted 9%, beating market expectations, on higher prescriptions of once-monthly haemophilia shot Hemlibra and recently launched eye drug Vabysmo.
Business
• 23 Oct 24